Pharma is ‘rising star’ in SSDs

By Silas Brown
21 Sep 2020

German hospital operator Asklepios Kliniken launched a Schuldschein on Monday with an initial target of €200m. Investors have doubled down on their interest in pharmaceutical firms this year and throughout the pandemic, prompting a substantial increase in the market’s exposure to the sector.

Five banks are arranging the Asklepios deal. BayernLB, BNP Paribas, Commerzbank, DZ Bank and Helaba are offering investors maturities of five, six, seven, eight and 10 years. There are also longer tenors available upon request.

Other pharmaceutical firms have also launched deals  recently. Eurofins, Gerresheimer and Phoenix Pharma have been ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial